New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives

Introduction: Lung cancer (LC) is the most common neoplasm worldwide, and 85% of these tumors are classified as non-small cell lung cancer (NSCLC). LC treatment was initially restricted to cytotoxic chemotherapy—platinum compounds associated with 3rd generation cytotoxic agents (paclitaxel, gemcitab...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mello, Ramon Andrade, Neves, Nathália Moisés, Tadokoro, Hakaru, Amaral, Giovanna Araújo, Castelo-Branco, Pedro, Zia, Victor André de Almeida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693900/
https://www.ncbi.nlm.nih.gov/pubmed/33153004
http://dx.doi.org/10.3390/jcm9113543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693900/
https://www.ncbi.nlm.nih.gov/pubmed/33153004
http://dx.doi.org/10.3390/jcm9113543

Ejemplares similares